GI OnDEMAND, a virtual integrated care platform, recently announced a partnership with Mindset Health, the creator of Nerva, a six-week gut-directed hypnotherapy program. The hypnotherapy program is delivered through a mobile app to help patients with irritable bowel syndrome (IBS) better manage their symptoms. GI OnDEMAND is a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., ...

In an upcoming study to be published in Gastroenterology, researchers at the Icahn School of Medicine at Mount Sinai and the University of North Carolina School of Medicine report on the clinical course of COVID-19 and risk factors for adverse outcomes in a large cohort of patients with IBD collected through an international registry. When the COVID-19 epidemic started to unfold ...

A systematic review and meta-analysis at the Farncombe Family Digestive Health Research Institute at McMaster in collaboration with the Society for the Study of Celiac Disease has determined there is a nine-fold increased risk of having IBD for patients with a previous diagnosis of celiac disease. Similarly, the risk for celiac disease is increased in IBD patients, though to a ...

What if you had to plan your outings based on how your stomach felt that day or where the nearest restroom is located? For many people with inflammatory bowel disease (IBD), their guts have an inordinate effect on their daily quality of life. One of the most common forms of IBD, called Crohn’s disease, is characterized by inflammation within the digestive tract ...

The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario, according to a study published by authors from several Canadian hospitals and ICES in the journal Gut. The authors studied trends in hospitalizations, surgeries and ...